From: Lung function and microbiota diversity in cystic fibrosis
Microbiota | Core taxa | Satellite taxa | |||||||
---|---|---|---|---|---|---|---|---|---|
Var. Exp (%) | pseudo-F | P (adj) | Var. Exp (%) | pseudo-F | P (adj) | Var. Exp (%) | pseudo-F | P (adj) | |
Age | 2.2 | 3.6 | 0.046 | 2.4 | 4 | 0.021 | 1.4 | 2.1 | 0.008 |
Antibiotics | |||||||||
Aztreonam | 1.4 | 2.1 | 0.013 | ||||||
Ceftazidime | 1.4 | 2 | 0.008 | ||||||
Colistin | 2.2 | 3.6 | 0.036 | 2.2 | 3.2 | 0.042 | 1.2 | 1.8 | 0.008 |
Flucloxacillin | 2.4 | 3.7 | 0.042 | 5.4 | 8.2 | 0.016 | 1.2 | 1.8 | 0.007 |
Meropenem | 4.4 | 6.6 | 0.028 | 2.4 | 3.6 | 0.033 | 2.4 | 3.5 | 0.021 |
Tobramycin | 1.8 | 2.9 | 0.040 | 2.2 | 3.2 | 0.032 | 1.2 | 1.9 | 0.007 |
Clinical status | 1 | 1.4 | 0.022 | ||||||
%FEV1 | 10.2 | 16.3 | 0.037 | 10.4 | 17.1 | 0.027 | 2.5 | 3 | 0.014 |
CFTR genotype | 1 | 1.6 | 0.007 | ||||||
Sex | 1.2 | 1.9 | 0.025 | ||||||
Region | 1.8 | 3 | 0.049 | 2 | 3.3 | 0.041 | 1.4 | 2.1 | 0.009 |
Distance | |||||||||
PCNM1 | 1.4 | 2.1 | 0.006 | ||||||
PCNM3 | 1 | 1.4 | 0.036 | ||||||
PCNM5 | 1.4 | 2.1 | 0.006 | ||||||
Clinical | 25.0 | 27.0 | 17.3 | ||||||
Distance | 3.8 | ||||||||
Total | 25.0 | 27.0 | 21.1 |